Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-02

Clinical Trial Update: Minirin Versus Oxybutynin for Nocturnal Enuresis in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Minirin (desmopressin) versus oxybutynin for nocturnal enuresis in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minirin (desmopressin)
  • oxybutynin (oxybutynin)

Snippet

Sponsor: Hormozgan University of Medical Sciences | Conditions: Nocturnal Enuresis | Phase 3 | Status: COMPLETED